What is BNBX's earnings growth forecast for 2026-2026?
(NASDAQ: BNBX) Bnb Plus's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 34.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,946.83%.
Bnb Plus's earnings in 2025 is -$69,487,620.
In 2026, BNBX is forecast to generate -$367,360,275 in earnings, with the lowest earnings forecast at -$352,953,990 and the highest earnings forecast at -$378,164,989.
What is BNBX's revenue growth forecast for 2026-2026?
(NASDAQ: BNBX) Bnb Plus's forecast annual revenue growth rate of 253.12% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,436.1%.
Bnb Plus's revenue in 2025 is $2,136,935.
In 2026, BNBX is forecast to generate $32,942,372 in revenue, with the lowest revenue forecast at $31,650,172 and the highest revenue forecast at $33,911,522.
What is BNBX's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: BNBX) forecast ROA is -8,278.65%, which is lower than the forecast US Diagnostics & Research industry average of 9.71%.
What is BNBX's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: BNBX) Bnb Plus's current Earnings Per Share (EPS) is -$134.23. In 2026, BNBX's EPS is forecast to hit -$84.15 (min: -$80.85, max: -$86.63).
What is BNBX's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: BNBX) forecast ROE is -15,939.29%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.